FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense ® PT/INR ...
DARESBURY, UNITED KINGDOM--(Marketwired - May 12, 2016) - Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") (OTCQB: ...
Results Published in Nursing 2014 Show that Self-testing Protocol Reduced Out-of-Range Coagulation Test Results and Need for Clinic Follow-up Alere Inc. (NYSE: ALR), a global leader in empowering ...
The most commonly transfused blood components in the United States are packed red blood cells (RBCs), fresh frozen plasma (FFP), and platelets. FFP contains clotting factors that reverse the ...
DALLAS, Texas — Two new trials examining the utility of genetic testing to guide warfarin dosing have come to divergent conclusions. One, the EU Pharmacogenetics of Anticoagulant Therapy (EU-PACT) ...
FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a subsidiary of i-SENS (KOSDAQ:099190), today announced that it has received approval for the sale of the Coag-Sense ® PT/INR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback